Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3635429014 | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 1479361015 | Cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3534583015 | Cream (basic dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3861571000005112 | creme | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | Type of drug preparation | false | Inferred relationship | Some | ||
| A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | kutan OG/ELLER transdermal doseringsform | false | Inferred relationship | Some | ||
| A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Is a | A dose form that displays properties between those of a liquid and those of a solid. | true | Inferred relationship | Some | ||
| A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Has state of matter (attribute) | A state of matter where particles form a definite shape and support their own weight but have the ability to flow like a liquid when pressure is applied. | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Drug cream, 0,5% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 0,01% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 2,5% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 0,025% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 0,1% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 0,25% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 1% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 0,02% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Drug cream, 0,05% | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Eye cream | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| oral creme | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Cutaneous cream | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Ear cream | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Nasal cream | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Vaginal cream | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Rectal cream | Is a | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Colloid sulfur 80 mg/g and resorcinol 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| stannofluorid 0,4 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| alphatocopherylacetat 50 IE/g creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| nitrofurazon 0,2 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| dienestrol 0,01 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Nonoxinol 20 mg/g vaginal cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Liquid paraffin+white soft paraffin cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| dimeticoncreme til topikal anvendelse | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| halobetasolpropionat 0,05 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| sulfanilamid 15 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| natriumfluorid 1,23 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| natriumfluorid 1,2 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| natriumfluorid 2,0 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Heparinoid 3 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| monobenzon 20 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| methylaminolevulinat 168 mg/g creme til topikal anvendelse | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Benzalkonium chloride 1 mg/g and dimeticone 220 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| eflornitin 11,5 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Hydroquinone 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| tazaroten 0,05 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| butenafinhydrochlorid 1 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| meclocyclinsulfosalicylat 1 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Gamolensyre 20 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely fluorouracil 10 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Avobenzone 2%/ecamsule 3%/octocrilene 10%/titanium dioxide 5% topical cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Avobenzone 2%/ecamsule 2%/octocrilene 10%/titanium dioxide 2% topical cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely fluorouracil 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely docosanol 100 milligram/1 milliliter conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| lanolin 4 % + zinkoxid 8 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| oxiconazolnitrat 1 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Fusidic acid 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| benzoylperoxid 10 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely benzydamine hydrochloride 30 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Benzoyl peroxide 50 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Povidone iodine 50 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| mafenidacetat 112 mg creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| fluocinolonacetonid 0,025 % + clioquinol 3 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| diphenhydramin 2 % + zinkacetat 0,1 % creme til topikal anvendelse | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely benzoyl peroxide 40 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Natlysolie 20 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| naftifinhydrochlorid 1,0 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| benzoylperoxid 8 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| betamethason 0,05 % + clotrimazol 1 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| eflornithinhydrochlorid 13,9 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| tazaroten 0,1 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Polynoxylin 100 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Azelaic acid 200 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| avobenzon 2 % + ecamsul 3 % + octocrylen 10 % creme til topikal anvendelse | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| avobenzon 2 % + ecamsul 2 % + octocrylen 10 % creme til topikal anvendelse | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| calcipotriol 50 µg/g creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Miconazole nitrate 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Ketoconazole 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| imiquimod 5 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely fluorouracil 50 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| mafenidacetat 85 mg/g creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| ammoniumlactat 12 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Sulconazole nitrate 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Bifonazole 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Dithranol 20 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely dithranol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely clocortolone pivalate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Dithranol 5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| hydrocortison 1 % + clotrimazol 1 % creme | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Dithranol 2.5 mg/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some | |
| Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | False | A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. | Inferred relationship | Some |
Page 1 of 2 End
Reference Sets
FHIR